These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4114202)

  • 21. Preliminary results of intracavitary treatment of craniopharyngioma with bleomycin.
    Broggi G; Giorgi C; Franzini A; Servello D; Solero CL
    J Neurosurg Sci; 1989; 33(1):145-8. PubMed ID: 2476533
    [No Abstract]   [Full Text] [Related]  

  • 22. Human primary brain tumor cell growth inhibition in serum-free medium optimized for neuron survival.
    Brewer GJ; LeRoux PD
    Brain Res; 2007 Jul; 1157():156-66. PubMed ID: 17537410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concentration of bleomycin in the brain tumor tissue determined by bioassay].
    Oashi T; Tabuchi K; Arimori M; Yoshizu H; Nobuto H
    Rinsho Shinkeigaku; 1972 Apr; 12(4):185-90. PubMed ID: 4118609
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy in the treatment of malignant brain tumors.
    Walker MD; Weiss HD
    Adv Neurol; 1975; 13():149-191. PubMed ID: 130061
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacologic bases of chemotherapy of brain tumors in children].
    Vassal G
    Bull Cancer; 1990; 77(7):699-713. PubMed ID: 2207360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Doughnut sign in brain scanning (author's transl)].
    Kamata K; Harano H; Hori S; Shinoara T; Toyama K
    No Shinkei Geka; 1974; 2(11-12):757-62. PubMed ID: 4477893
    [No Abstract]   [Full Text] [Related]  

  • 27. [Glyco-active corticosteroid hormones and the nervous system: study of their transit across the blood-cerebrospinal fluid barrier. Deductions for therapeutic purposes].
    Genova R; Cavazzuti GB; Galli V
    Clin Pediatr (Bologna); 1968 Aug; 50(8):435-52. PubMed ID: 4302733
    [No Abstract]   [Full Text] [Related]  

  • 28. Heterogeneity in the expression of markers for drug resistance in brain tumors.
    Andersson U; Malmer B; Bergenheim AT; Brännström T; Henriksson R
    Clin Neuropathol; 2004; 23(1):21-7. PubMed ID: 14986930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT-guided stereotactic injection of radionuclide in treatment of brain tumors.
    Tian ZM; Liu ZH; Kang GQ; Li SY; Wang YG; Diao GP; Dong GZ
    Chin Med J (Engl); 1992 Dec; 105(12):987-91. PubMed ID: 1338588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption].
    Yamada K; Takahama H; Nakai O; Takanashi T; Hosoya T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of brain tumors using radioisotopes.
    Oldendorf WH
    Bull Los Angeles Neurol Soc; 1967 Oct; 32(4):220-33. PubMed ID: 6056725
    [No Abstract]   [Full Text] [Related]  

  • 32. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol].
    Miyagami M; Kagawa Y; Tsubokawa T
    No Shinkei Geka; 1985 Sep; 13(9):955-63. PubMed ID: 2999632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemo-meningeal permeability to corticoids].
    Bernard R; Garrigues J; Rouby M
    Pediatrie; 1965 Sep; 20(6):719-24. PubMed ID: 5850060
    [No Abstract]   [Full Text] [Related]  

  • 34. Corticosteroid therapy in patients with cerebral tumors: benefits, mechanisms, problems, practicalities.
    Gutin PH
    Semin Oncol; 1975 Mar; 2(1):49-56. PubMed ID: 795033
    [No Abstract]   [Full Text] [Related]  

  • 35. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging.
    Wilkinson ID; Jellineck DA; Levy D; Giesel FL; Romanowski CA; Miller BA; Griffiths PD
    Neurosurgery; 2006 Apr; 58(4):640-6; discussion 640-6. PubMed ID: 16575327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The uptake, distribution and anti-tumor activity of bleomycin in gliomas in the mouse.
    Hayakawa T; Ushio Y; Mogami H; Horibata K
    Eur J Cancer (1965); 1974 Mar; 10(3):137-42. PubMed ID: 4139017
    [No Abstract]   [Full Text] [Related]  

  • 38. Permeability in brain tumors.
    Tator CH; Schwartz ML
    J Neurosurg; 1971 Mar; 34(3):460-2. PubMed ID: 5547331
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxic effects of bleomycin on the hypothalamus following its administration into a cystic craniopharyngioma.
    Haisa T; Ueki K; Yoshida S
    Br J Neurosurg; 1994; 8(6):747-50. PubMed ID: 7536420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lactates in brain tumors. A comparative study with non-tumoral tissue].
    Dohr H; Heussen B; Scheithauer-Hoffmann E; Simmert A
    Acta Neurochir (Wien); 1970 Apr; 22(1):79-84. PubMed ID: 4986420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.